News
Abeona Therapeutics' pz-cel gene therapy shows the most durable wound healing in RDEB patients. See why I rate ABEO stock a ...
Wells Fargo notes that Summit Therapeutics (SMMT) partner Akeso (AKESF) received approval from China’s NMPA for ivonescimab as a monotherapy ...
Summit Therapeutics' partner Akeso received FDA approval for penpulimab-kcqx in NPC, while ivonescimab showed strong data in ...
Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Limited, has announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...
Skin injury results when the skin to adhesive attachment is stronger than skin cell to skin cell attachment. As a result, the epidermal layers separate or the epidermis separates completely from ...
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...
A new study reveals that chronic stress activates immune cells that travel to the brain, amplify inflammation, and heighten ...
Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...
Janux Therapeutics, Inc.’s JANX share price has dipped by 5.83%, which has investors questioning if this is right time to buy.
DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 inhibitor. The report provides product descriptions, patent details, and ...
A novel combination therapy offers better outcomes for patients with KRAS G12C metastatic colorectal cancer that have stopped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results